FDA suspends clinical trial for investigational diabetes drug

The FDA placed a clinical hold on an investigational new drug application for a second-generation MetAP2 inhibitor in development for the treatment of type 2 diabetes, citing cardiovascular safety concerns, Zafgen announced in a press release. The FDA ci https://www.healio.com/endocrinology/diabetes/news/online/%7B81e950dc-8709-4789-9527-298ffc137c9d%7D/fda-suspends-clinical-trial-for-investigational-diabetes-drug